Follow us...


Search News Archives





View Channel

Laboratory Products



View Channel

Separation Science



View Channel

Microscopy | Image Analysis



View Channel

IT Solutions and Laboratory Automation



View Channel


Conferences | Events

New Biotinylated 10E4 Heparan Sulfate Antibodies

publication date: May 26, 2021
author/source: AMS Biotechnology (Europe) Ltd



AMSBIO has launched two new biotinylated formats of the 10E4 Heparan Sulfate antibody (high and low biotin) along with a starter pack to allow scientists to test both formats at a reduced cost.

Biotinylated antibodies are often used for the detection of low-abundance proteins. The process of biotin-labeling is also frequently used as a non-radiative labeling method for proteins, and as a protein purification technique.

Biotin-conjugation of the Heparan Sulfate 10E4 antibody confers many advantages, by removing the need for conjugated secondary antibodies to quantify the level of detection/binding in immunological assays.

Jacob van den Born and co-workers have used biotinylated Heparan Sulfate 10E4 antibody in double and triple staining experiments*; giving them the freedom to choose the best fluorophore (conjugated to streptavidin) to visualize HS in combination with other antigens. Employing this strategy reduces expenditure on specific secondary antibodies, which are very expensive.

As the 10E4 antibody is a mouse monoclonal antibody, conjugated secondary antibodies will detect any endogenous mouse immunoglobulins already present in the sample as well as the added monoclonal antibody, leading to the risk of “false-positive” results in experiments with adult mouse samples. Using biotinylated Heparan Sulfate 10E4 antibody and enzyme-linked streptavidin, is a way of avoiding this problem.


* Talsma, Poppelaars, Dam, Meter-Arkema, Vivès, Gál, Boons, Chopra, Naggi, Seelen, Berger, Daha, Stegeman, van den Born & COMBAT Consortium. (2020). MASP-2 Is a Heparin-Binding Protease; Identification of Blocking Oligosaccharides. Frontiers in Immunology, 11, 732.


About AMS Biotechnology

Founded in 1987, AMS Biotechnology (AMSBIO) is recognized today as a leading transatlantic company contributing to the acceleration of discovery through the provision of cutting-edge life science technology, products and services for research and development in the medical, nutrition, cosmetics and energy industries. AMSBIO has in-depth expertise in extracellular matrices to provide elegant solutions for studying cell motility, migration, invasion and proliferation. This expertise in cell culture and the ECM allows AMSBIO to partner with clients in tailoring cell systems to enhance organoid and spheroid screening outcomes using a variety of 3D culture systems, including organ-on-a-chip microfluidics. For drug discovery research, AMSBIO offers assays, recombinant proteins and cell lines. Drawing upon a huge and comprehensive biorepository, AMSBIO is widely recognised as a leading provider of high-quality tissue specimens (including custom procurement) from both human and animal tissues. The company provides unique clinical grade products for stem cell and cell therapy applications these include high quality solutions for viral delivery (lentivirus, adenovirus and adeno-associated virus) in addition to GMP cryopreservation technology.


View Company Profile | Recent news

If you have not logged into the website then please enter your details below.


Subscribe to any of our newsletters for the latest on new laboratory products, industry news, case studies and much more!

Newsletters from Lab Bulletin


Request your free copies HERE




Popular this Month

Top 10 most popular articles this month


Today's Picks




Looking for a Supplier?

Search by company or by product


Company Name:






Please note Lab Bulletin does not sell, supply any of the products featured on this website. If you have an enquiry, please use the contact form below the article or company profile and we will send your request to the supplier so that they can contact you directly.

Lab Bulletin is published by newleaf marketing communications ltd.


Media Partners